Peter DeMuth

Director Técnico/Científico/I+D en ELICIO THERAPEUTICS, INC. .

Fortuna: - $ al 31/05/2024

38 años

Health Technology

Finance

Consumer Services

Cargos activos de Peter DeMuth

Empresas	Cargo	Inicio	Fin
ELICIO THERAPEUTICS, INC.	Director Técnico/Científico/I+D	01/01/2022	-

Empresas	Cargo	Inicio	Fin
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Director Técnico/Científico/I+D	01/08/2017	01/06/2023

Massachusetts Institute of Technology	Doctorate Degree
University of Maryland	Undergraduate Degree

Internacional

Estados Unidos

Operativa

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
ELICIO THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Empresas privadas

Health Technology